These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33115289)

  • 21. Is preoperative chemoradiation in rectal cancer patients modulated by ACE inhibitors? Results from the Dutch Cancer Registry.
    Rombouts AJ; Hugen N; Verhoeven RH; Kuiper JG; Poortmans PM; de Wilt JH; Nagtegaal ID
    Radiother Oncol; 2019 Sep; 138():86-92. PubMed ID: 31252299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health outcomes and economic consequences of using angiotensin-converting enzyme inhibitors in comparison with angiotensin receptor blockers in the treatment of arterial hypertension in the contemporary Polish setting.
    Wrona W; Budka K; Filipiak KJ; Niewada M; Wojtyniak B; Zdrojewski T
    Kardiol Pol; 2016; 74(9):1016-24. PubMed ID: 27112942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: New-onset diabetes mellitus stratified by statin use.
    Shin J; Kim H; Yim HW; Kim JH; Lee S; Kim HS
    J Clin Pharm Ther; 2022 Jan; 47(1):97-103. PubMed ID: 34668200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies.
    Qin Y; Chen T; Chen Q; Lv JY; Qi N; Wu C; He J
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):503-11. PubMed ID: 26786323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective cohort analysis of the effects of renin-angiotensin system inhibitors on spinal fusion in ACDF patients.
    Perdomo-Pantoja A; Shamoun F; Holmes C; Ishida W; Ramhmdani S; Cottrill E; Bydon A; Lo SL; Theodore N; Witham TF
    Spine J; 2019 Aug; 19(8):1354-1361. PubMed ID: 31059820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
    Wang PT; Huang YB; Lin MY; Chuang PF; Hwang SJ
    Kaohsiung J Med Sci; 2012 Sep; 28(9):477-83. PubMed ID: 22974666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with renin-angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity-matched study in the community.
    Egido JJ; Gomez R; Romero SP; Andrey JL; Ramirez D; Rodriguez A; Pedrosa MJ; Gomez F
    Int J Clin Pract; 2019 Jun; 73(6):e13317. PubMed ID: 30694579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
    Li PC; Huang RY; Yang YC; Hsieh KP; Yang YH
    BMC Cancer; 2022 Apr; 22(1):430. PubMed ID: 35443635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withholding vs. Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Before Non-cardiac Surgery in Older Patients: Study Protocol for a Multicenter Randomized Controlled Trial.
    Yang YF; Zhu YJ; Long YQ; Liu HY; Shan XS; Feng XM; Peng K; Ji FH
    Front Med (Lausanne); 2021; 8():654700. PubMed ID: 33859991
    [No Abstract]   [Full Text] [Related]  

  • 30. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuation of Renin-Angiotensin-Aldosterone Inhibitors Does Not Impact Renal Function Among Patients Undergoing Percutaneous Nephrolithotomy.
    Patel N; Cohen BR; De S; Kartha G; Li I; Sarkissian C; Calle J; Monga M
    J Endourol; 2017 Jun; 31(6):577-582. PubMed ID: 28340535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study.
    Ho CM; Lee CH; Lee MC; Zhang JF; Wang JY; Hu RH; Lee PH
    BMC Cancer; 2018 Apr; 18(1):401. PubMed ID: 29631561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
    Kristensen KE; Torp-Pedersen C; Gislason GH; Egfjord M; Rasmussen HB; Hansen PR
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):733-40. PubMed ID: 25633315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors reduce albuminuria more than angiotensin receptor blockers in patients with type 2 diabetes.
    Al-Sayed NA; Gao T; Wells BJ; Yu C; Zimmerman RS
    Endocr Pract; 2013; 19(4):579-86. PubMed ID: 23425642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of perioperative, renal and oncologic outcomes in robotic-assisted versus open partial nephrectomy.
    Tan JL; Frydenberg M; Grummet J; Hanegbi U; Snow R; Mann S; Begashaw K; Moon D
    ANZ J Surg; 2018 Mar; 88(3):E194-E199. PubMed ID: 28922687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan.
    Huang SH; Hsu CN; Yu SH; Cham TM
    BMC Public Health; 2012 May; 12():288. PubMed ID: 22521158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
    Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
    Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
    Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
    Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review and Meta-Analysis of Comparative Studies Reporting Perioperative Outcomes of Robot-Assisted Partial Nephrectomy Versus Open Partial Nephrectomy.
    Xia L; Wang X; Xu T; Guzzo TJ
    J Endourol; 2017 Sep; 31(9):893-909. PubMed ID: 27305835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.